Research Article
Elevated Serum IGFBP-2 and CTGF Levels Are Associated with Disease Activity in Patients with Dermatomyositis
Table 2
Spearman correlations of IGFBPs with disease activity assessed by MITAX.
| | IGFBP1 | IGFBP2 | IGFBP3 | IGFBP4 | IGFBP6 | CTGF |
| Characteristics | Subgroup patients | Sample size | | value | | value | | value | | value | | value | | value | Constitutional | All DM patients | 64 | 0.472 | <0.001 | 0.260 | 0.038 | -0.078 | 0.540 | 0.226 | 0.072 | -0.010 | 0.939 | 0.247 | 0.049 | DM-non-ILD | 32 | 0.446 | 0.011 | 0.326 | 0.069 | -0.191 | 0.295 | 0.302 | 0.093 | -0.017 | 0.926 | 0.299 | 0.097 | DM-ILD | 32 | 0.508 | 0.003 | 0.168 | 0.357 | 0.059 | 0.750 | 0.123 | 0.502 | -0.016 | 0.929 | 0.180 | 0.325 | Cutaneous disease activity | All DM patients | 64 | 0.270 | 0.031 | 0.257 | 0.040 | -0.346 | 0.005 | 0.026 | 0.837 | 0.063 | 0.622 | 0.233 | 0.064 | DM-non-ILD | 32 | 0.227 | 0.211 | 0.108 | 0.557 | -0.161 | 0.377 | 0.265 | 0.142 | -0.010 | 0.958 | 0.427 | 0.015 | DM-ILD | 32 | 0.365 | 0.040 | 0.436 | 0.013 | -0.471 | 0.007 | -0.157 | 0.392 | 0.158 | 0.387 | 0.070 | 0.704 | Skeletal disease activity | All DM patients | 64 | 0.054 | 0.672 | -1.330 | 0.293 | 0.142 | 0.264 | 0.001 | 0.992 | -0.136 | 0.284 | 0.011 | 0.929 | DM-non-ILD | 32 | 0.134 | 0.463 | -0.093 | 0.612 | 0.059 | 0.748 | 0.013 | 0.946 | -0.083 | 0.650 | -0.003 | 0.986 | DM-ILD | 32 | -0.052 | 0.779 | -0.190 | 0.299 | 0.190 | 0.299 | 0.010 | 0.955 | -0.176 | 0.336 | -0.017 | 0.925 | Gastrointestinal disease activity | All DM patients | 64 | 0.415 | 0.001 | 0.330 | 0.008 | -0.104 | 0.411 | 0.188 | 0.136 | -0.067 | 0.598 | 0.134 | 0.290 | DM-non-ILD | 32 | 0.385 | 0.030 | 0.160 | 0.382 | 0.003 | 0.987 | 0.264 | 0.144 | -0.276 | 0.126 | 0.220 | 0.226 | DM-ILD | 32 | 0.461 | 0.008 | 0.479 | 0.006 | -0.151 | 0.410 | 0.170 | 0.352 | 0.161 | 0.377 | 0.038 | 0.838 | Pulmonary disease activity | All DM patients | 64 | 0.169 | 0.181 | 0.135 | 0.287 | 0.105 | 0.407 | 0.300 | 0.016 | 0.080 | 0.531 | 0.049 | 0.698 | DM-non-ILD | 32 | 0.254 | 0.161 | -0.184 | 0.314 | 0.070 | 0.704 | 0.212 | 0.244 | -0.108 | 0.556 | 0.129 | 0.483 | DM-ILD | 32 | 0.420 | 0.017 | 0.338 | 0.058 | -0.046 | 0.803 | 0.391 | 0.027 | 0.061 | 0.742 | 0.130 | 0.480 | Cardiovascular disease activity | All DM patients | 64 | 0.367 | 0.030 | 0.184 | 0.145 | -0.071 | 0.578 | 0.263 | 0.036 | 0.052 | 0.683 | 0.229 | 0.069 | DM-non-ILD | 32 | 0.517 | 0.002 | 0.331 | 0.064 | -0.079 | 0.666 | 0.4050.405 | 0.021 | 0.126 | 0.493 | 0.322 | 0.073 | Muscle disease activity | All DM patients | 64 | 0.406 | 0.001 | 0.336 | 0.007 | -0.087 | 0.493 | 0.094 | 0.458 | -0.079 | 0.536 | 0.192 | 0.128 | DM-non-ILD | 32 | 0.496 | 0.004 | 0.249 | 0.169 | -0.161 | 0.379 | 0.174 | 0.342 | -0.038 | 0.837 | 0.220 | 0.226 | DM-ILD | 32 | 0.382 | 0.031 | 0.481 | 0.005 | 0.075 | 0.684 | 0.225 | 0.216 | 0.014 | 0.940 | 0.191 | 0.294 | Global disease activity | All DM patients | 64 | 0.584 | < 0.001 | 0.380 | 0.002 | -0.183 | 0.147 | 0.280 | 0.025 | 0.014 | 0.915 | 0.292 | 0.019 | DM-non-ILD | 32 | 0.589 | < 0.001 | 0.261 | 0.150 | -0.164 | 0.368 | 0.386 | 0.029 | -0.053 | 0.772 | 0.394 | 0.026 | DM-ILD | 32 | 0.629 | < 0.001 | 0.478 | 0.006 | -0.203 | 0.266 | 0.176 | 0.336 | 0.077 | 0.674 | 0.113 | 0.537 |
|
|
Bold fonts indicate statistical significance.
|